Vaccination and allergy: EAACI position paper, practical aspects

Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non‐allergic patients unless risks associated with vaccination outweigh the gains. Whereas the n...

Full description

Saved in:
Bibliographic Details
Published inPediatric allergy and immunology Vol. 28; no. 7; pp. 628 - 640
Main Authors Nilsson, Lennart, Brockow, Knut, Alm, Johan, Cardona, Victoria, Caubet, Jean‐Christoph, Gomes, Eva, Jenmalm, Maria C., Lau, Susanne, Netterlid, Eva, Schwarze, Jürgen, Sheikh, Aziz, Storsaeter, Jann, Skevaki, Chrysanthi, Terreehorst, Ingrid, Zanoni, Giovanna
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2017
Subjects
Adjuvant
Adverse event
Allergies
Allergy
Anaphylaxis
Anaphylaxis - immunology
Child
Child, Preschool
Children
Clinical Medicine
Dermatologi och venereologi
Dermatology and Venereal Diseases
Fear
Humans
Hypersensitivity - etiology
Hypersensitivity - immunology
Immunization
Infant
Klinisk medicin
Lungmedicin och allergi
Medical and Health Sciences
Medicin och hälsovetenskap
Patients
Pediatrics
Pediatrik
Public health
Respiratory Medicine and Allergy
Risk factors
Vaccination
Vaccination - adverse effects
Vaccines
Vaccines - adverse effects
Vaccines - immunology
adverse event
allergy
anaphylaxis
adjuvant
vaccination
Online AccessGet full text

Cover

Abstract Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non‐allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine‐triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.
AbstractList Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non‐allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine‐triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.
Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.
Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as nonallergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting less than 1/100,000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed. This article is protected by copyright. All rights reserved.
Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed.
Author Alm, Johan
Cardona, Victoria
Jenmalm, Maria C.
Lau, Susanne
Zanoni, Giovanna
Gomes, Eva
Brockow, Knut
Nilsson, Lennart
Caubet, Jean‐Christoph
Storsaeter, Jann
Schwarze, Jürgen
Skevaki, Chrysanthi
Netterlid, Eva
Terreehorst, Ingrid
Sheikh, Aziz
Author_xml – sequence: 1
  givenname: Lennart
  orcidid: 0000-0002-5680-6367
  surname: Nilsson
  fullname: Nilsson, Lennart
  email: Lennart.J.Nilsson@Regionostergotland.se
  organization: University Hospital
– sequence: 2
  givenname: Knut
  surname: Brockow
  fullname: Brockow, Knut
  organization: Technical University Munich
– sequence: 3
  givenname: Johan
  orcidid: 0000-0002-9062-4479
  surname: Alm
  fullname: Alm, Johan
  organization: Sachs′ Children and Youth Hospital and Karolinska Institutet, Södersjukhuset
– sequence: 4
  givenname: Victoria
  surname: Cardona
  fullname: Cardona, Victoria
  organization: Hospital Universitari Vall d'Hebron
– sequence: 5
  givenname: Jean‐Christoph
  surname: Caubet
  fullname: Caubet, Jean‐Christoph
  organization: University of Geneva
– sequence: 6
  givenname: Eva
  surname: Gomes
  fullname: Gomes, Eva
  organization: CHP
– sequence: 7
  givenname: Maria C.
  orcidid: 0000-0002-2117-5366
  surname: Jenmalm
  fullname: Jenmalm, Maria C.
  organization: Linköping University
– sequence: 8
  givenname: Susanne
  surname: Lau
  fullname: Lau, Susanne
  organization: Charité Universitätsmedizin
– sequence: 9
  givenname: Eva
  surname: Netterlid
  fullname: Netterlid, Eva
  organization: The Public Health Agency of Sweden
– sequence: 10
  givenname: Jürgen
  surname: Schwarze
  fullname: Schwarze, Jürgen
  organization: The University of Edinburgh
– sequence: 11
  givenname: Aziz
  surname: Sheikh
  fullname: Sheikh, Aziz
  organization: The University of Edinburgh
– sequence: 12
  givenname: Jann
  surname: Storsaeter
  fullname: Storsaeter, Jann
  organization: Norwegian Institute of Public Health
– sequence: 13
  givenname: Chrysanthi
  surname: Skevaki
  fullname: Skevaki, Chrysanthi
  organization: Philipps University Marburg
– sequence: 14
  givenname: Ingrid
  surname: Terreehorst
  fullname: Terreehorst, Ingrid
  organization: AMC
– sequence: 15
  givenname: Giovanna
  surname: Zanoni
  fullname: Zanoni, Giovanna
  organization: University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28779496$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141773$$DView record from Swedish Publication Index
https://lup.lub.lu.se/record/aa0f19ec-544d-4b1d-94fc-031fbf3a4740$$DView record from Swedish Publication Index
oai:portal.research.lu.se:publications/aa0f19ec-544d-4b1d-94fc-031fbf3a4740$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:137324379$$DView record from Swedish Publication Index
BookMark eNqNkl9vFCEUxYmpsdvqg1_ATOKLJp0WBgYGn9xsq26yiT5oX2_uMEylsjMjzKTZby_7pz40biIJgcDvHDhwz8hJ13eWkNeMXrLUrgZ0l6xQsnhGZoxrnXPKqxMyo5qWuWSlOiVnMd5TyhSX7AU5LSqltNByRj7eojGuw9H1XYZdk6H3NtxtPmQ38_limQ19dLu9AQcbLrIhoBmdQZ9hHKwZ40vyvEUf7avDeE5-fLr5vviSr75-Xi7mq9zIShc5olJNU8uKVTVFUbLWlJUsJWO0aFutpWqwLa01xnJTWIO65KqsdS2aqqkt8nOS733jgx2mGobg1hg20KODw9KvNLMgUjDOE49H-aEPI3oINloM5if4aStMlE_JtmkjINKWaWugFKIBUbMGtGgNUM7auuUolKDpjNXRM_w0pF4fvP_T7njEa3c7hz7cgXcTMMGU2kZ8t-eH0P-ebBxh7aKx3mNn-ykC04WUlWSqSOjbJ-h9P4UufViiZMGo4HpLvTlQU722zd8LPJZLAq72gAl9jMG2YNy4e7ExoPPAKGwLElJBwq4gk-L9E8Wj6b_Yg_uD83ZzHIRv8-Ve8QdODfBM
CitedBy_id crossref_primary_10_1002_hsr2_787
crossref_primary_10_1016_j_reval_2018_02_213
crossref_primary_10_1111_pai_13821
crossref_primary_10_1111_pai_14236
crossref_primary_10_1002_clt2_12152
crossref_primary_10_29262_ram_v69iSupl1_989
crossref_primary_10_3390_vaccines9050412
crossref_primary_10_1016_j_alit_2021_04_003
crossref_primary_10_3389_falgy_2022_948380
crossref_primary_10_1016_j_rmra_2024_11_017
crossref_primary_10_1111_all_15183
crossref_primary_10_1016_j_jaip_2019_06_040
crossref_primary_10_1080_1744666X_2020_1814745
crossref_primary_10_26416_Aler_6_4_2022_7402
crossref_primary_10_1111_all_14134
crossref_primary_10_2147_JAA_S386611
crossref_primary_10_1007_s15007_021_4762_4
crossref_primary_10_1111_cea_13968
crossref_primary_10_1016_j_paed_2024_12_003
crossref_primary_10_1016_j_jacig_2023_100101
crossref_primary_10_26416_Aler_5_2_2021_4910
crossref_primary_10_1186_s12948_020_00136_3
crossref_primary_10_25142_osp_2022_006
crossref_primary_10_17116_profmed2023260923
crossref_primary_10_1007_s15007_018_1707_7
crossref_primary_10_1016_j_waojou_2022_100734
crossref_primary_10_1016_j_jaip_2023_05_004
crossref_primary_10_1002_prp2_1224
crossref_primary_10_1016_j_vaccine_2021_09_048
crossref_primary_10_1111_pai_13967
crossref_primary_10_1016_j_jaci_2017_12_971
crossref_primary_10_1016_j_perped_2022_04_011
crossref_primary_10_1016_j_waojou_2021_100541
crossref_primary_10_3390_biomedicines10061260
crossref_primary_10_1016_j_reval_2024_104166
crossref_primary_10_2174_1381612829666221024154951
crossref_primary_10_1111_all_14794
crossref_primary_10_1016_j_jaip_2021_08_002
crossref_primary_10_1016_j_vaccine_2018_03_076
crossref_primary_10_1007_s00105_020_04751_8
crossref_primary_10_1016_j_vaccine_2020_08_073
crossref_primary_10_15690_pf_v19i1_2350
crossref_primary_10_1007_s15007_024_6371_5
crossref_primary_10_1016_j_jacig_2023_100089
crossref_primary_10_34084_bshr_1542004
crossref_primary_10_29296_25879979_2023_06_01
crossref_primary_10_1007_s15007_022_5054_3
crossref_primary_10_1111_cod_14350
crossref_primary_10_1007_s40629_020_00160_4
crossref_primary_10_1016_j_clim_2024_110220
crossref_primary_10_1136_bmjopen_2023_072722
crossref_primary_10_1111_all_14840
crossref_primary_10_15557_PiMR_2023_0048
crossref_primary_10_1111_all_15414
crossref_primary_10_1111_all_14726
crossref_primary_10_1016_j_jaip_2022_04_026
crossref_primary_10_1186_s13052_020_00843_2
crossref_primary_10_1007_s40521_022_00311_8
crossref_primary_10_3389_fpubh_2022_878081
crossref_primary_10_1016_j_jaip_2019_01_025
crossref_primary_10_3390_vaccines9010038
crossref_primary_10_3390_biomedicines11020620
crossref_primary_10_1016_j_waojou_2021_100517
crossref_primary_10_1007_s40629_022_00215_8
crossref_primary_10_3390_ijms22052586
crossref_primary_10_5694_mja2_51593
crossref_primary_10_1016_j_rmclc_2020_04_003
crossref_primary_10_1007_s00228_022_03399_8
crossref_primary_10_1111_all_14739
crossref_primary_10_1007_s40629_024_00306_8
crossref_primary_10_3390_vaccines10040576
crossref_primary_10_1016_j_jaip_2021_03_041
crossref_primary_10_1080_21645515_2021_1997034
crossref_primary_10_3390_vaccines12091059
crossref_primary_10_1007_s00281_019_00777_w
crossref_primary_10_1007_s15011_021_4618_y
crossref_primary_10_3390_vaccines9060553
crossref_primary_10_3390_vaccines9030221
crossref_primary_10_7759_cureus_40444
crossref_primary_10_21101_cejph_a8170
crossref_primary_10_1055_a_1353_1387
crossref_primary_10_1007_s15007_019_1989_4
crossref_primary_10_1097_ACI_0000000000000769
crossref_primary_10_1097_ACI_0000000000000762
crossref_primary_10_1016_j_reval_2021_01_005
crossref_primary_10_20515_otd_948570
crossref_primary_10_3389_fpubh_2022_999354
crossref_primary_10_3390_nu13082637
crossref_primary_10_1007_s40259_022_00536_8
crossref_primary_10_1016_j_rmra_2020_08_019
crossref_primary_10_1080_21645515_2022_2082207
crossref_primary_10_1159_000539505
crossref_primary_10_33920_MED_12_2112_07
crossref_primary_10_4045_tidsskr_23_0140
crossref_primary_10_1007_s40521_019_00215_0
crossref_primary_10_1016_j_jaip_2022_09_019
crossref_primary_10_1002_ski2_412
crossref_primary_10_1007_s40629_018_0077_8
crossref_primary_10_21615_cesmedicina_6282
crossref_primary_10_3238_PersPneumo_2018_03_09_01
crossref_primary_10_1007_s15014_019_1497_8
crossref_primary_10_1097_INF_0000000000002625
Cites_doi 10.1016/j.vaccine.2004.02.033
10.1159/000346350
10.1016/S0140-6736(11)60678-8
10.1016/j.jaci.2015.07.048
10.1016/j.vaccine.2009.04.020
10.1093/aje/kwn253
10.1136/bmj.h6291
10.1016/j.jaip.2015.03.011
10.1016/j.vaccine.2006.05.130
10.1186/s40413-016-0120-5
10.1111/cea.12882
10.1016/j.jaci.2007.11.034
10.1016/j.vaccine.2008.06.083
10.1016/j.vaccine.2006.05.110
10.1007/s10096-012-1595-9
10.1503/cmaj.080916
10.1016/S0140-6736(86)90397-1
10.1111/j.1399-3038.1994.tb00228.x
10.1542/peds.2007-1653
10.1016/j.anai.2013.03.001
10.1542/peds.2014-0723
10.1016/j.jcpa.2007.04.012
10.1542/peds.111.3.e282
10.1111/all.12437
10.1111/j.1651-2227.2012.02737.x
10.1016/j.vaccine.2004.07.016
10.1159/000237376
10.1542/peds.2012-2617
10.1111/j.1399-3038.2010.01018.x
10.1016/j.vaccine.2005.07.069
10.1007/978-1-4614-4726-9_6
10.1016/j.vaccine.2006.05.029
10.1186/s40169-014-0043-0
10.1542/peds.2008-0013
10.1007/s00431-014-2318-2
10.1037/a0027387
10.1001/archpedi.157.12.1184
10.1111/pai.12548
10.1136/bcr.02.2012.5797
10.1111/pai.12102
10.1016/j.jaci.2015.08.001
10.1111/j.1399-3038.2009.00950.x
10.1016/S0264-410X(99)00480-6
10.1016/j.vaccine.2004.06.042
10.1016/j.jaci.2010.11.014
10.1002/ppul.20089
10.1016/0264-410X(94)00017-H
10.1111/j.1398-9995.1998.tb03841.x
10.1016/S0264-410X(03)00531-0
10.1111/j.1600-0536.2008.01394.x
10.1016/S0264-410X(01)00230-4
10.1016/j.jaci.2011.04.046
10.1136/adc.2004.051714
10.1097/DER.0b013e31825228cf
10.1542/peds.112.4.815
10.1111/j.1600-0536.2008.01474.x
10.1111/cea.12059
10.1186/1465-9921-11-8
10.1007/s00431-012-1841-2
10.1016/j.jaci.2013.08.007
10.1053/ajcd.2002.29945
10.1016/j.jaci.2016.10.037
10.1016/j.vaccine.2010.06.009
10.1097/ACI.0b013e328354395d
10.1111/j.1398-9995.2008.01696.x
10.1016/j.vaccine.2011.12.118
10.1016/j.jaci.2014.12.1925
10.1016/j.jaci.2012.04.003
10.1111/j.1365-2222.2010.03557.x
10.1016/j.vaccine.2007.10.071
10.1007/s004310051264
10.1503/cmaj.081238
10.1016/j.aller.2015.01.004
10.1016/S0140-6736(95)92039-0
10.1016/j.jaci.2007.04.035
ContentType Journal Article
Copyright 2017 The Authors. Published by John Wiley & Sons Ltd.
2017 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.
Copyright © 2017 John Wiley & Sons A/S
Copyright_xml – notice: 2017 The Authors. Published by John Wiley & Sons Ltd.
– notice: 2017 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.
– notice: Copyright © 2017 John Wiley & Sons A/S
CorporateAuthor Occupational and Environmental Dermatology
Faculty of Medicine
Lunds universitet
Yrkes- och miljödermatologi
Department of Clinical Sciences, Malmö
Medicinska fakulteten
Lund University
Institutionen för kliniska vetenskaper, Malmö
CorporateAuthor_xml – name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Yrkes- och miljödermatologi
– name: Lund University
– name: Institutionen för kliniska vetenskaper, Malmö
– name: Occupational and Environmental Dermatology
– name: Lunds universitet
– name: Department of Clinical Sciences, Malmö
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
NAPCQ
7X8
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
AGCHP
D95
DOI 10.1111/pai.12762
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
SWEPUB Lunds universitet full text
SWEPUB Lunds universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef



MEDLINE - Academic
AIDS and Cancer Research Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1399-3038
EndPage 640
ExternalDocumentID oai_swepub_ki_se_494933
oai_portal_research_lu_se_publications_aa0f19ec_544d_4b1d_94fc_031fbf3a4740
oai_lup_lub_lu_se_aa0f19ec_544d_4b1d_94fc_031fbf3a4740
oai_DiVA_org_liu_141773
28779496
10_1111_pai_12762
PAI12762
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Medical Research Council
  grantid: G1000758
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29O
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J8S
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
NAPCQ
7X8
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
AGCHP
D95
ID FETCH-LOGICAL-c6892-aa77ddb6818b0a451fc586561102ff9967daf5eecce3c2eca95375b9b4d8dbea3
IEDL.DBID DR2
ISSN 0905-6157
1399-3038
IngestDate Mon Aug 25 03:37:39 EDT 2025
Thu Aug 21 06:44:42 EDT 2025
Thu Jul 03 05:11:20 EDT 2025
Thu Aug 21 06:23:06 EDT 2025
Fri Jul 11 02:40:27 EDT 2025
Fri Jul 25 18:55:28 EDT 2025
Mon Jul 21 05:51:06 EDT 2025
Tue Jul 01 01:25:21 EDT 2025
Thu Apr 24 23:11:34 EDT 2025
Wed Jan 22 16:57:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords adverse event
allergy
anaphylaxis
adjuvant
vaccination
Language English
License Attribution-NonCommercial
http://creativecommons.org/licenses/by-nc/4.0
2017 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6892-aa77ddb6818b0a451fc586561102ff9967daf5eecce3c2eca95375b9b4d8dbea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-2117-5366
0000-0002-9062-4479
0000-0002-5680-6367
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.12762
PMID 28779496
PQID 1962104392
PQPubID 105695
PageCount 13
ParticipantIDs swepub_primary_oai_swepub_ki_se_494933
swepub_primary_oai_portal_research_lu_se_publications_aa0f19ec_544d_4b1d_94fc_031fbf3a4740
swepub_primary_oai_lup_lub_lu_se_aa0f19ec_544d_4b1d_94fc_031fbf3a4740
swepub_primary_oai_DiVA_org_liu_141773
proquest_miscellaneous_1926686172
proquest_journals_1962104392
pubmed_primary_28779496
crossref_citationtrail_10_1111_pai_12762
crossref_primary_10_1111_pai_12762
wiley_primary_10_1111_pai_12762_PAI12762
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2017
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Montpellier
PublicationTitle Pediatric allergy and immunology
PublicationTitleAlternate Pediatr Allergy Immunol
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 22
2010; 11
2013; 2
2017; 47
2013; 24
2002; 13
2013; 764
2004; 23
2014; 69
2014; 173
2014; 133
2003; 157
2012; 12
2013; 161
2003; 112
2003; 111
2014; 134
2011; 127
2007; 137
2012; 130
2010; 21
1986; 2
2000; 18
2011; 128
2006; 24
2004; 38
2015; 136
2010; 28
2015; 43
2001; 19
2008; 26
2009; 123
2013; 60
2008; 63
2013; 110
2012; 23
1998; 53
2012; 21
2007; 25
2011; 378
2015; 4
2012; 101
2015; 3
2012
2009; 60
2005; 90
1995; 13
2007; 120
2008; 59
2008; 168
1993; 147
2008; 121
2009; 27
2012; 31
2010; 40
2017; 139
2012; 30
2013; 32
2015; 351
1995; 345
1996; 111
1999; 158
2016; 137
1998; 1
2013
2013; 131
2008; 179
2016; 27
2013; 172
2012; 43
1994; 5
2016; 9
2003; 22
e_1_2_10_23_1
e_1_2_10_46_1
e_1_2_10_69_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
Andersen DV (e_1_2_10_56_1) 2013; 60
e_1_2_10_70_1
e_1_2_10_2_1
e_1_2_10_72_1
WHO (e_1_2_10_19_1) 2013
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_74_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_76_1
e_1_2_10_55_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_57_1
e_1_2_10_78_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_80_1
e_1_2_10_82_1
e_1_2_10_61_1
e_1_2_10_84_1
e_1_2_10_29_1
e_1_2_10_63_1
e_1_2_10_27_1
e_1_2_10_65_1
e_1_2_10_25_1
e_1_2_10_48_1
Spycher BD (e_1_2_10_79_1) 2008; 121
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
Cates CJ (e_1_2_10_47_1) 2013; 2
e_1_2_10_20_1
e_1_2_10_41_1
e_1_2_10_71_1
Michalska‐Krzanowska G (e_1_2_10_67_1) 2012; 21
e_1_2_10_73_1
e_1_2_10_52_1
e_1_2_10_3_1
Kwittken PL (e_1_2_10_10_1) 1993; 147
e_1_2_10_75_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_77_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_59_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
Grange JM (e_1_2_10_58_1) 1998; 1
e_1_2_10_60_1
e_1_2_10_81_1
e_1_2_10_62_1
e_1_2_10_83_1
e_1_2_10_64_1
e_1_2_10_85_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_66_1
e_1_2_10_26_1
e_1_2_10_68_1
References_xml – volume: 22
  start-page: 3375
  year: 2004
  end-page: 3385
  article-title: No epidemiological evidence for infant vaccinations to cause allergic disease
  publication-title: Vaccine
– volume: 12
  start-page: 383
  year: 2012
  end-page: 388
  article-title: Safety of influenza vaccines
  publication-title: Curr Opin Allergy Clin Immunol
– volume: 69
  start-page: 1026
  year: 2014
  end-page: 1045
  article-title: Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
  publication-title: Allergy
– volume: 133
  start-page: 688
  year: 2014
  end-page: 695
  article-title: Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta‐analysis
  publication-title: J Allergy Clin Immunol
– volume: 59
  start-page: 183
  year: 2008
  end-page: 184
  article-title: Aluminium chloride hexahydrate at 2% is insufficient to trace contact allergy to aluminium
  publication-title: Contact Dermatitis
– volume: 137
  start-page: 861
  year: 2016
  end-page: 867
  article-title: Highly increased levels of IgE antibodies vaccine components in children with influenza vaccine‐associated anaphylaxis
  publication-title: J Allergy Clin Immunol
– volume: 128
  start-page: 215
  year: 2011
  end-page: 218
  article-title: Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy
  publication-title: J Allergy Clin Immunol
– volume: 161
  start-page: 274
  year: 2013
  end-page: 278
  article-title: Administration of yellow fever vaccine in patients with egg allergy
  publication-title: Int Arch Allergy Immunol
– volume: 27
  start-page: 433
  year: 2016
  end-page: 437
  article-title: Anaphylaxis to pneumococcal vaccine; CRM(197): novel cause of vaccine allergy
  publication-title: Pediatr Allergy Immunol
– volume: 23
  start-page: 664
  year: 2004
  end-page: 667
  article-title: Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)
  publication-title: Vaccine
– volume: 111
  start-page: 262
  year: 1996
  end-page: 267
  article-title: Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life
  publication-title: Int Arch Allergy Immunol
– volume: 131
  start-page: 283
  year: 2013
  end-page: 289
  article-title: Vaccination site and risk of local reactions in children 1 through 6 years of age
  publication-title: Pediatrics
– volume: 136
  start-page: 376
  year: 2015
  end-page: 381
  article-title: Safety of live attenuated influenza vaccine in atopic children with egg allergy
  publication-title: J Allergy Clin Immunol
– volume: 21
  start-page: 403
  year: 2012
  end-page: 408
  article-title: Tryptase in diagnosing adverse suspected anaphylactic reaction
  publication-title: Adv Clin Exp Med
– volume: 13
  start-page: 669
  year: 1995
  end-page: 673
  article-title: Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium‐adsorbed and fluid DT‐vaccines
  publication-title: Vaccine
– volume: 43
  start-page: 304
  year: 2015
  end-page: 325
  article-title: Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components
  publication-title: Allergol Immunopathol (Madr)
– volume: 2
  start-page: 522
  year: 1986
  end-page: 523
  article-title: Exacerbation of eczema by formalin‐containing hepatitis B vaccine in formaldehyde‐allergic patient
  publication-title: Lancet
– volume: 130
  start-page: 25
  year: 2012
  end-page: 43
  article-title: Adverse reactions to vaccines practice parameter 2012 update
  publication-title: J Allergy Clin Immunol
– volume: 134
  start-page: 721
  year: 2014
  end-page: 728
  article-title: Pertussis immunization in infancy and adolescent asthma medication
  publication-title: Pediatrics
– volume: 31
  start-page: 2549
  year: 2012
  end-page: 2557
  article-title: The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing
  publication-title: Eur J Clin Microbiol Infect Dis
– volume: 147
  start-page: 128
  year: 1993
  end-page: 129
  article-title: MMR vaccine and neomycin allergy
  publication-title: Am J Dis Child
– volume: 127
  start-page: 130
  year: 2011
  end-page: 137
  article-title: Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine
  publication-title: J Allergy Clin Immunol
– volume: 5
  start-page: 118
  year: 1994
  end-page: 123
  article-title: Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines
  publication-title: Pediatr Allergy Immunol
– volume: 121
  start-page: 626
  year: 2008
  end-page: 631
  article-title: Timing of routine vaccinations and the risk of childhood asthma
  publication-title: J Allergy Clin Immunol
– volume: 137
  start-page: S46
  issue: Suppl 1
  year: 2007
  end-page: S50
  article-title: Mechanisms underlying adverse reactions to vaccines
  publication-title: J Comp Pathol
– year: 2012
  article-title: Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80
  publication-title: BMJ Case Rep
– volume: 22
  start-page: 64
  year: 2003
  end-page: 69
  article-title: Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer
  publication-title: Vaccine
– volume: 2
  start-page: CD000364
  year: 2013
  article-title: Vaccines for preventing influenza in people with asthma
  publication-title: Cochrane Database Syst Rev
– volume: 179
  start-page: 525
  year: 2008
  end-page: 533
  article-title: Anaphylaxis following quadrivalent human papillomavirus vaccination
  publication-title: CMAJ
– volume: 9
  start-page: 32
  year: 2016
  article-title: International consensus (ICON): allergic reactions to vaccines
  publication-title: World Allergy Organ J
– volume: 13
  start-page: 3
  year: 2002
  end-page: 9
  article-title: Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal
  publication-title: Am J Contact Dermatol
– volume: 173
  start-page: 1297
  year: 2014
  end-page: 1307
  article-title: How common are long‐lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study
  publication-title: Eur J Pediatr
– volume: 28
  start-page: 5731
  year: 2010
  end-page: 5737
  article-title: Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC)
  publication-title: Vaccine
– volume: 137
  start-page: 868
  year: 2016
  end-page: 878
  article-title: Risk of anaphylaxis after vaccination in children and adults
  publication-title: J Allergy Clin Immunol
– volume: 25
  start-page: 570
  year: 2007
  end-page: 576
  article-title: Vaccine adverse events reported in post‐marketing study of the Kitasato Institute from 1994 to 2004
  publication-title: Vaccine
– volume: 23
  start-page: 102
  year: 2012
  end-page: 109
  article-title: Hypersensitivity reactions to vaccine constituents: a case series and review of the literature
  publication-title: Dermatitis
– volume: 60
  start-page: A4573
  year: 2013
  article-title: MMR vaccination of children with egg allergy is safe
  publication-title: Dan Med J
– volume: 112
  start-page: 815
  year: 2003
  end-page: 820
  article-title: Risk of anaphylaxis after vaccination of children and adolescents
  publication-title: Pediatrics
– volume: 168
  start-page: 1277
  year: 2008
  end-page: 1283
  article-title: Measles‐mumps‐rubella vaccination and asthma‐like disease in early childhood
  publication-title: Am J Epidemiol
– volume: 47
  start-page: 593
  year: 2017
  end-page: 596
  article-title: Vaccination management in children and adults with mastocytosis
  publication-title: Clin Exp Allergy
– volume: 53
  start-page: 1195
  year: 1998
  end-page: 1201
  article-title: Pertussis‐IgE and atopic disease
  publication-title: Allergy
– volume: 3
  start-page: 794
  year: 2015
  end-page: 795
  article-title: Ovalbumin content in the yellow fever vaccine
  publication-title: J Allergy Clin Immunol Pract
– volume: 378
  start-page: 526
  year: 2011
  end-page: 535
  article-title: Addressing the vaccine confidence gap
  publication-title: Lancet
– volume: 19
  start-page: 4720
  year: 2001
  end-page: 4726
  article-title: Assessment of injection site reactions to an acellular pertussis‐based combination including novel use of skin tests with vaccine antigens
  publication-title: Vaccine
– volume: 1
  start-page: 84
  year: 1998
  end-page: 88
  article-title: Complications of bacille Calmette‐Guérin (BCG) vaccination and immunotherapy and their management
  publication-title: Commun Dis Public Health
– volume: 179
  start-page: 503
  year: 2008
  article-title: HPV vaccine risk and reality
  publication-title: CMAJ
– volume: 172
  start-page: 171
  year: 2013
  end-page: 177
  article-title: Sixty‐four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium‐adsorbed vaccines. Prognosis and outcome after booster vaccination
  publication-title: Eur J Pediatr
– volume: 21
  start-page: 1076
  year: 2010
  end-page: 1085
  article-title: Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years
  publication-title: Pediatr Allergy Immunol
– volume: 18
  start-page: 2055
  year: 2000
  end-page: 2058
  article-title: IgE sensitization to gelatin: the probable role of gelatin‐containing diphtheria‐tetanus‐acellular pertussis (DTaP) vaccines
  publication-title: Vaccine
– volume: 764
  start-page: 81
  year: 2013
  end-page: 98
  article-title: Building confidence in vaccines
  publication-title: Adv Exp Med Biol
– volume: 123
  start-page: 771
  year: 2009
  end-page: 778
  article-title: Allergic Disease and Atopic Sensitization in Children in Relation to Measles Vaccination and Measles Infection
  publication-title: Pediatrics
– volume: 110
  start-page: 397
  year: 2013
  end-page: 401
  article-title: Allergic reactions after immunization
  publication-title: Ann Allergy Asthma Immunol
– volume: 4
  start-page: 3
  year: 2015
  article-title: Vaccination in children with allergy to non active vaccine components
  publication-title: Clin Transl Med
– volume: 120
  start-page: 478
  year: 2007
  end-page: 481
  article-title: Clinical Immunization Safety Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines
  publication-title: J Allergy Clin Immunol
– volume: 26
  start-page: 427
  year: 2008
  end-page: 429
  article-title: Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal‐free or thimerosal‐containing vaccine
  publication-title: Vaccine
– volume: 345
  start-page: 1249
  year: 1995
  article-title: Anaphylaxis after hepatitis B vaccination
  publication-title: Lancet
– volume: 60
  start-page: 41
  year: 2009
  end-page: 49
  article-title: There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy
  publication-title: Contact Dermatitis
– volume: 63
  start-page: 1464
  year: 2008
  end-page: 1472
  article-title: Early atopic disease and early childhood immunization – is there a link?
  publication-title: Allergy
– volume: 24
  start-page: 703
  year: 2006
  end-page: 707
  article-title: Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
  publication-title: Vaccine
– volume: 11
  start-page: 8
  year: 2010
  article-title: Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One
  publication-title: Respir Res
– volume: 21
  start-page: 301
  year: 2010
  end-page: 306
  article-title: Childhood immunization and atopic disease into middle‐age ‐ a prospective cohort study
  publication-title: Pediatr Allergy Immunol
– volume: 38
  start-page: 329
  year: 2004
  end-page: 334
  article-title: Infant immunization and the occurrence of atopic disease in Dutch and German children: a nested case‐control study
  publication-title: Pediatr Pulmonol
– year: 2012
– volume: 139
  start-page: 1710
  year: 2017
  end-page: 1713
  article-title: Anaphylaxis after Zoster vaccine: implicating alpha‐gal as a possible mechanism
  publication-title: J Allergy Clin Immunol
– volume: 40
  start-page: 1116
  year: 2010
  end-page: 1129
  article-title: British Society for Allergy and Clinical Immunology guidelines for the management of egg allergy
  publication-title: Clin Exp Allergy
– volume: 24
  start-page: S106
  issue: Suppl 3
  year: 2006
  end-page: S113
  article-title: Chapter 12: prophylactic HPV vaccines: underlying mechanisms
  publication-title: Vaccine
– volume: 26
  start-page: D10
  issue: Suppl 4
  year: 2008
  end-page: D16
  article-title: Safety and efficacy of live attenuated influenza vaccine in children 2‐7 years of age
  publication-title: Vaccine
– volume: 111
  start-page: e282
  year: 2003
  end-page: e288
  article-title: Transient suppression of atopy in early childhood is associated with high vaccination coverage
  publication-title: Pediatrics
– volume: 121
  start-page: e646
  year: 2008
  end-page: e652
  article-title: Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria‐tetanus‐acellular pertussis vaccination
  publication-title: Pediatrics
– volume: 121
  start-page: 626
  year: 2008
  end-page: 631
  article-title: Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma
  publication-title: J Allergy Clin Immunol
– volume: 90
  start-page: 567
  year: 2005
  end-page: 573
  article-title: Timing of routine immunisations and subsequent hay fever risk
  publication-title: Arch Dis Child
– volume: 30
  start-page: 1865
  year: 2012
  end-page: 1874
  article-title: A genomics‐based approach to assessment of vaccine safety and immunogenicity in children
  publication-title: Vaccine
– volume: 158
  start-page: 989
  year: 1999
  end-page: 994
  article-title: Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria‐tetanus‐pertussis immunization
  publication-title: Eur J Pediatr
– volume: 351
  start-page: h6291
  year: 2015
  article-title: Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
  publication-title: BMJ
– volume: 32
  start-page: 146
  year: 2013
  end-page: 155
  article-title: Debunking vaccination myths: strong risk negations can increase perceived vaccination risks
  publication-title: Health Psychol
– volume: 157
  start-page: 1184
  year: 2003
  end-page: 1189
  article-title: Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow‐up of a randomized controlled trial of 3 vaccines
  publication-title: Arch Pediatr Adolesc Med
– volume: 24
  start-page: 521
  year: 2013
  end-page: 526
  article-title: Allergic reactions to vaccines
  publication-title: Pediatr Allergy Immunol
– volume: 24
  start-page: 6351
  year: 2006
  end-page: 6355
  article-title: An internet‐based survey on parental attitudes towards immunization
  publication-title: Vaccine
– volume: 23
  start-page: 579
  year: 2004
  end-page: 584
  article-title: Post‐marketing surveillance of immediate allergic reactions: polygeline‐based versus polygeline‐free pediatric TBE vaccine
  publication-title: Vaccine
– volume: 43
  start-page: 249
  year: 2012
  end-page: 254
  article-title: Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy
  publication-title: Clin Exp Allergy
– volume: 27
  start-page: 3885
  year: 2009
  end-page: 3889
  article-title: Vaccination‐associated anaphylaxis in adults: diagnostic testing ruling out IgE‐mediated vaccine allergy
  publication-title: Vaccine
– year: 2013
– volume: 101
  start-page: 941
  year: 2012
  end-page: 945
  article-title: A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis
  publication-title: Acta Paediatr
– ident: e_1_2_10_27_1
  doi: 10.1016/j.vaccine.2004.02.033
– ident: e_1_2_10_61_1
  doi: 10.1159/000346350
– ident: e_1_2_10_81_1
  doi: 10.1016/S0140-6736(11)60678-8
– ident: e_1_2_10_21_1
  doi: 10.1016/j.jaci.2015.07.048
– ident: e_1_2_10_74_1
  doi: 10.1016/j.vaccine.2009.04.020
– ident: e_1_2_10_36_1
  doi: 10.1093/aje/kwn253
– ident: e_1_2_10_51_1
  doi: 10.1136/bmj.h6291
– ident: e_1_2_10_60_1
  doi: 10.1016/j.jaip.2015.03.011
– volume-title: Immunization Safety Surveillance Guidelines for immunization programme managers on surveillance of adverse events following immunization
  year: 2013
  ident: e_1_2_10_19_1
– ident: e_1_2_10_39_1
  doi: 10.1016/j.vaccine.2006.05.130
– ident: e_1_2_10_77_1
  doi: 10.1186/s40413-016-0120-5
– ident: e_1_2_10_76_1
  doi: 10.1111/cea.12882
– ident: e_1_2_10_78_1
  doi: 10.1016/j.jaci.2007.11.034
– volume: 121
  start-page: 626
  year: 2008
  ident: e_1_2_10_79_1
  article-title: Timing of routine vaccinations and the risk of childhood asthma
  publication-title: J Allergy Clin Immunol
– ident: e_1_2_10_46_1
  doi: 10.1016/j.vaccine.2008.06.083
– ident: e_1_2_10_64_1
  doi: 10.1016/j.vaccine.2006.05.110
– ident: e_1_2_10_82_1
– ident: e_1_2_10_48_1
  doi: 10.1007/s10096-012-1595-9
– ident: e_1_2_10_62_1
  doi: 10.1503/cmaj.080916
– ident: e_1_2_10_9_1
  doi: 10.1016/S0140-6736(86)90397-1
– volume: 21
  start-page: 403
  year: 2012
  ident: e_1_2_10_67_1
  article-title: Tryptase in diagnosing adverse suspected anaphylactic reaction
  publication-title: Adv Clin Exp Med
– ident: e_1_2_10_75_1
  doi: 10.1111/j.1399-3038.1994.tb00228.x
– ident: e_1_2_10_24_1
  doi: 10.1542/peds.2007-1653
– ident: e_1_2_10_49_1
  doi: 10.1016/j.anai.2013.03.001
– ident: e_1_2_10_33_1
  doi: 10.1542/peds.2014-0723
– ident: e_1_2_10_22_1
  doi: 10.1016/j.jcpa.2007.04.012
– ident: e_1_2_10_29_1
  doi: 10.1542/peds.111.3.e282
– ident: e_1_2_10_20_1
  doi: 10.1111/all.12437
– ident: e_1_2_10_55_1
  doi: 10.1111/j.1651-2227.2012.02737.x
– ident: e_1_2_10_66_1
  doi: 10.1016/j.vaccine.2004.07.016
– ident: e_1_2_10_15_1
  doi: 10.1159/000237376
– ident: e_1_2_10_25_1
  doi: 10.1542/peds.2012-2617
– ident: e_1_2_10_35_1
  doi: 10.1111/j.1399-3038.2010.01018.x
– ident: e_1_2_10_13_1
  doi: 10.1016/j.vaccine.2005.07.069
– ident: e_1_2_10_84_1
  doi: 10.1007/978-1-4614-4726-9_6
– ident: e_1_2_10_26_1
  doi: 10.1016/j.vaccine.2006.05.029
– ident: e_1_2_10_2_1
  doi: 10.1186/s40169-014-0043-0
– ident: e_1_2_10_34_1
  doi: 10.1542/peds.2008-0013
– ident: e_1_2_10_71_1
  doi: 10.1007/s00431-014-2318-2
– volume: 2
  start-page: CD000364
  year: 2013
  ident: e_1_2_10_47_1
  article-title: Vaccines for preventing influenza in people with asthma
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_10_85_1
  doi: 10.1037/a0027387
– ident: e_1_2_10_32_1
  doi: 10.1001/archpedi.157.12.1184
– ident: e_1_2_10_5_1
  doi: 10.1111/pai.12548
– ident: e_1_2_10_65_1
  doi: 10.1136/bcr.02.2012.5797
– ident: e_1_2_10_43_1
  doi: 10.1111/pai.12102
– ident: e_1_2_10_4_1
  doi: 10.1016/j.jaci.2015.08.001
– ident: e_1_2_10_28_1
  doi: 10.1111/j.1399-3038.2009.00950.x
– ident: e_1_2_10_54_1
  doi: 10.1016/S0264-410X(99)00480-6
– volume: 60
  start-page: A4573
  year: 2013
  ident: e_1_2_10_56_1
  article-title: MMR vaccination of children with egg allergy is safe
  publication-title: Dan Med J
– ident: e_1_2_10_11_1
  doi: 10.1016/j.vaccine.2004.06.042
– ident: e_1_2_10_45_1
  doi: 10.1016/j.jaci.2010.11.014
– ident: e_1_2_10_37_1
  doi: 10.1002/ppul.20089
– ident: e_1_2_10_16_1
  doi: 10.1016/0264-410X(94)00017-H
– ident: e_1_2_10_40_1
  doi: 10.1111/j.1398-9995.1998.tb03841.x
– ident: e_1_2_10_70_1
  doi: 10.1016/S0264-410X(03)00531-0
– ident: e_1_2_10_72_1
  doi: 10.1111/j.1600-0536.2008.01394.x
– volume-title: Green Book
  ident: e_1_2_10_52_1
– volume: 147
  start-page: 128
  year: 1993
  ident: e_1_2_10_10_1
  article-title: MMR vaccine and neomycin allergy
  publication-title: Am J Dis Child
– ident: e_1_2_10_23_1
  doi: 10.1016/S0264-410X(01)00230-4
– ident: e_1_2_10_42_1
  doi: 10.1016/j.jaci.2011.04.046
– volume: 1
  start-page: 84
  year: 1998
  ident: e_1_2_10_58_1
  article-title: Complications of bacille Calmette‐Guérin (BCG) vaccination and immunotherapy and their management
  publication-title: Commun Dis Public Health
– ident: e_1_2_10_80_1
  doi: 10.1136/adc.2004.051714
– ident: e_1_2_10_3_1
  doi: 10.1097/DER.0b013e31825228cf
– ident: e_1_2_10_59_1
  doi: 10.1542/peds.112.4.815
– ident: e_1_2_10_73_1
  doi: 10.1111/j.1600-0536.2008.01474.x
– ident: e_1_2_10_6_1
  doi: 10.1111/cea.12059
– ident: e_1_2_10_31_1
  doi: 10.1186/1465-9921-11-8
– ident: e_1_2_10_69_1
  doi: 10.1007/s00431-012-1841-2
– ident: e_1_2_10_38_1
  doi: 10.1016/j.jaci.2013.08.007
– ident: e_1_2_10_8_1
  doi: 10.1053/ajcd.2002.29945
– ident: e_1_2_10_14_1
  doi: 10.1016/j.jaci.2016.10.037
– ident: e_1_2_10_83_1
  doi: 10.1016/j.vaccine.2010.06.009
– ident: e_1_2_10_44_1
  doi: 10.1097/ACI.0b013e328354395d
– ident: e_1_2_10_30_1
  doi: 10.1111/j.1398-9995.2008.01696.x
– ident: e_1_2_10_17_1
  doi: 10.1016/j.vaccine.2011.12.118
– ident: e_1_2_10_50_1
  doi: 10.1016/j.jaci.2014.12.1925
– ident: e_1_2_10_18_1
  doi: 10.1016/j.jaci.2012.04.003
– ident: e_1_2_10_57_1
  doi: 10.1111/j.1365-2222.2010.03557.x
– ident: e_1_2_10_7_1
  doi: 10.1016/j.vaccine.2007.10.071
– ident: e_1_2_10_41_1
  doi: 10.1007/s004310051264
– ident: e_1_2_10_63_1
  doi: 10.1503/cmaj.081238
– ident: e_1_2_10_53_1
  doi: 10.1016/j.aller.2015.01.004
– ident: e_1_2_10_12_1
  doi: 10.1016/S0140-6736(95)92039-0
– ident: e_1_2_10_68_1
  doi: 10.1016/j.jaci.2007.04.035
SSID ssj0017361
Score 2.5267127
SecondaryResourceType review_article
Snippet Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 628
SubjectTerms Adjuvant
Adverse event
Allergies
Allergy
Anaphylaxis
Anaphylaxis - immunology
Child
Child, Preschool
Children
Clinical Medicine
Dermatologi och venereologi
Dermatology and Venereal Diseases
Fear
Humans
Hypersensitivity - etiology
Hypersensitivity - immunology
Immunization
Infant
Klinisk medicin
Lungmedicin och allergi
Medical and Health Sciences
Medicin och hälsovetenskap
Patients
Pediatrics
Pediatrik
Public health
Respiratory Medicine and Allergy
Risk factors
Vaccination
Vaccination - adverse effects
Vaccines
Vaccines - adverse effects
Vaccines - immunology
Title Vaccination and allergy: EAACI position paper, practical aspects
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.12762
https://www.ncbi.nlm.nih.gov/pubmed/28779496
https://www.proquest.com/docview/1962104392
https://www.proquest.com/docview/1926686172
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141773
https://lup.lub.lu.se/record/aa0f19ec-544d-4b1d-94fc-031fbf3a4740
oai:portal.research.lu.se:publications/aa0f19ec-544d-4b1d-94fc-031fbf3a4740
http://kipublications.ki.se/Default.aspx?queryparsed=id:137324379
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB5qH8QXrddGa4ki0gez5DKXRF8MdUsrVIrYUkQY5lqXLrthd_NQf71nJpPQ6grFh0DInJzdmTPnzHcmM98g9CYXgLpLCplqQVSCAXEnlSAsoYXC0lBZltrNQx5_oYen-PM5Od9AH_q9MB0_xDDh5jzDx2vn4EIurzl5IyajLGc-_rq1Wg4QfR2oozJWeK7UtEoJpEeEBVYht4pnePPmWPQXwBzYQ28CVz_yHDxAP_r_3C04uRy1KzlSv_6gc_zPSm2h-wGRxnXXhR6iDTN7hO4eh2_uj9HHM6HgzlswFjMdu9NXFhdX7-NxXe8fxf2yr7gRjVm8i8O-K1Ap_DbO5RN0ejD-tn-YhHMXEkXLKk-EYExrSWEsl6nAJLMKzAlAC8CItZAgMS0sMWB8U6jcKFGRghFZSaxLLY0onqLN2XxmtlFcZoJSZm2ZuXNlKJGKsYrlpTJMG1Afob3eAlwFUnJ3NsaU98kJtAj3LRKh14No0zFxrBPa6c3IgzMuOQQZSGwBeUHxq6EY3Mh9GxEzM2-dDCCV0sG5CD3rzD_8CiSVELUqGqG3XX8YShw396fJWc3niws-nbSQSGWMFREarxGctg1cEi6-NFyI1GaVUZxgrDmWmeYVtopDkLXSFgIznEbo-xo9XV7GAxnUz6CvuTbLe0vl62oTHl1OnE7HXFRAbfZ8l_13q_OT-sjfPL-96At0L3cIyW_r3EGbq0VrXgK-W8lddCfHJ7venX8Dd7FOJQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBalg20vu1_cdZs3xujDHHyRLHvsYaZNSbamjNGWUhhC1zY0OCaJH7ZfvyNbNu2WQdmDwVjHJ5GOjvQdWfoOQu9iDqg7SyFSTYgMMCDuIOeEBmkisdCpyDJl1yEnh-noGH85Jacb6FN3Fqblh-gX3KxnNOO1dXC7IH3Fyys-HUQxtQPwLZvR2zLn733vyaMimjRsqWEeEgiQCHW8QnYfT__q9dnoL4jZ84deh67N3LN_H_3o_nW75eRyUK_EQP76g9Dxf6v1AN1zoNQv2l70EG3o8hG6PXGf3R-jzydcwl1jRJ-XyrcJWBbnPz_6w6LYHfvdzi-_4pVefPDd0StQyZuTnMsn6Hh_eLQ7ClzqhUCmWR4HnFOqlEhhOhchxyQyEiwKWAvwiDEQI1HFDdFgf53IWEuek4QSkQusMiU0T56izXJe6ufIzyKeptSYLLKpZVIiJKU5jTOpqdKg3kM7nQmYdLzkNj3GjHXxCbQIa1rEQ2970aol41gntN3ZkTl_XDIYZyC2BfAFxW_6YvAk-3mEl3peWxkAK5lFdB561tq__xWIK2HgylMPvW87RF9i6bn3picFmy_O2WxaQywVUZp4aLhGcFZXcAm42FIzzkMT5VoygrFiWESK5dhIBuOsESbhmOLQQ2dr9LShGXN8UBdOX3VlofeGytfVxj26nFqdlrwogdrsNH32363OvhXj5mbr5qKv0Z3R0eSAHYwPv75Ad2MLmJpTnttoc7Wo9UuAeyvxqvHq30iJUWo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELaqIlVcEJRXoJSAEOqBoDz8SNoLUburLtBqD7SquFh-lhWrbLTbPfDvGTtO1IpF6iFSFE8m8jgz_saPzwh9yAWg7pJCploQlWBA3EklCEtoobA0VJalduOQZ-f09AJ_vSJXW-io3wvT8UMMA27OM3y8dg7eanvLyVsx-5zlzMXfB26yz63nyvF0mEJghSdLTauUQH5EWKAVcst4hlfvdkb_IMyBPvQucvVdz_gxehQwY1x3jfwEbZlmF-2chVnxp-jLpVBw520ci0bH7nyU5fWfw3hU18eTuF-YFbeiNctPcdgZBSqF32i5eoYuxqMfx6dJOBkhUbSs8kQIxrSWFHpbmQpMMqvA4ACFAC5YCykM08ISA81jCpUbJSpSMCIriXWppRHFc7TdLBrzEsVlJihl1paZO_mFEqkYq1heKsO0AfUROuhNxFWgDXenV8x5nz6ANbm3ZoTeD6Jtx5WxSWivtzMP7rLiEAYg9QRsBMXvhmL40d3shWjMYu1kAEuUDnBF6EXXPsNXIO2DuFLRCH3sGmwocezZJ7PLmi-W13w-W0OqkzFWRGi0QXC-buGScPGV4UKkNquM4gRjzbHMNK-wVRzCoJW2EJjhNEI_N-jpMice6Jp-BX3trXHYeyrfVJvw6PfM6XTcQgXU5sD_nv-3Op_WE3_z6v6ib9HO9GTMv0_Ov71GD3MHZ_wezD20fbNcmzcAxm7kvne6v7L5L-s
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vaccination+and+allergy%3A+EAACI+position+paper%2C+practical+aspects&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Nilsson%2C+L&rft.au=Brockow%2C+K&rft.au=Alm%2C+J&rft.au=Cardona%2C+V&rft.date=2017-11-01&rft.issn=0905-6157&rft.volume=28&rft.issue=7&rft.spage=628&rft_id=info:doi/10.1111%2Fpai.12762&rft.externalDocID=oai_swepub_ki_se_494933
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon